CAVH in continuous renal replacement therapy is often regarded as one of most important advances in intensive care medicine in recent years. CAVH has been used widely for patients with acute renal failure combined with cardiovascular instability, severe fluid overload, cerebral edema or hyper catabolism, systemic inflammatory response syndrome and sepsis, acute respiratory distress and cardiopulmonary bypass. The continuous renal replacement therapy has to be started early to prevent multi-organ dysfunction.
Hemofiltration ; Renal Replacement Therapy

No abstract available.
Renal Replacement Therapy*

Introduction: Approximately 120 per million population develop kidney failure, translating to about 10,000 Filipinos needing to replace their kidney function per year. If without the appropriate intervention, those having kidney failure will surely die. The study aims to evaluate the compliance of hemodialysis (HD) patients to renal replacement therapy (RRT) in two dialysis centers in Iloilo City, and to compare the prevalence of non-adherence in between groups. Methods: A cross-sectional study where subjects answered the End-Stage Renal Disease–Adherence Questionnaire (ESRD-AQ). Results: Of the 102 patients, 59.8% (n=61) were enrolled. The mean age was 47 years with average HD vintage of 30 months. More females were non-adherent to HD treatment, 17.1% vs.15.4%; whereas more males were non-adherent to the remainder descriptors (medications, 11.5% vs. 8.6%; fluid restriction, 23.1% vs. 17.1%; and diet recommendations 30.8% vs. 25.7%). There were less non-adherent patients than adherent ones (HD attendance, 9,803.92 vs. 50,000; medications, 5,882.35 vs. 53,921.57; fluid restriction, 11,764.71 vs. 48,039.22; and diet, 16,666.67 vs. 43,137.25 per 100,000). There were significant differences in their behaviors toward HD attendance (p=0.000); shortening of HD treatment (p=0.000); duration of shortening HD (p=0.000); adherence to medications (p=0.000); to fluid (p=0.000); and to diet (p=0.000). Both groups demonstrated the same level of perception and understanding towards the importance of HD (p=0.306 and 0.096, respectively). There was no significant difference in their perception to medications (p=0.427); however, figures illustrate a significant difference in their levels of understanding towards its importance (p=0.001). Adherent subjects have better perception and understanding in fluid restriction regimen and dietary recommendations as data show significant differences in between groups (p=0.000 and 0.000; and p=0.001 and 0.004, respectively). Conclusion The compliance of adherent subjects to HD treatment, medications, fluid restriction protocol and dietary recommendations was more adequate. The non-adherent subjects were less prevalent than adherent subjects.
Renal Replacement Therapy

From October 2004 to March 2005, 13 acute renal failure patients were treated by Continuous Renal Replacement Therapy (CRRT) in Cho Ray hospital. Results: Multiple trauma accounted for 31%, sepsis 31%, multiple system organ failure 15%, APACHE II score were 24.97  6.35. Continuous Intravenous Hemodialysis (CVVHD) had been performed in 39% of patients, CVVH 31%, CVVHDF 15% and SCUF 15%. Patients’ serum concentration of creatinine and BUN decreased step by step and stable. Serum concentrations of creatinine and BUN before and after CRRT were 5.60  2.34 mg% and 49.60  35.19 mg%, respectively. Mean duration of CRRT was 28.0  10.9 hours. 8/13 patients partly recovered their renal functions. Mortality rate was 61.54%. Hemodynamic instability patients (76.92%) were well-tolerated with CRRT. Applying dose of ultrafiltration 35 ml/kg/h for septic patients improved dose and time of increased mean blood pressure. During over 400 hours of CRRT, there were not yet major complications reported.
Renal Replacement Therapy ; Intensive Care

No abstract available.
Aged* ; Humans ; Renal Replacement Therapy*

No abstract available.
Critical Illness ; Humans ; Renal Replacement Therapy ; Vancomycin

No abstract available.
Acute Kidney Injury* ; Cardiopulmonary Bypass* ; Renal Replacement Therapy*

More than thirty years after its introduction as a modality of renal replacement therapy (RRT), peritoneal dialysis (PD) has now become an established form of RRT. There were 70,211 patients receiving RRT at the end of 2,012 in Korea, and PD accounted for 10.8% of them. The rate for PD patients per million population has grown by 24% during the past 10 years. In this paper, physiology of peritoneal dialysis, assessment of peritoneal membrane transport function, updated target of solute removal, and potential complications of peritoneal dialysis will be discussed.
Humans ; Korea ; Membranes ; Peritoneal Dialysis* ; Physiology ; Renal Replacement Therapy

More than thirty years after its introduction as a modality of renal replacement therapy (RRT), peritoneal dialysis (PD) has now become an established form of RRT. There were 70,211 patients receiving RRT at the end of 2,012 in Korea, and PD accounted for 10.8% of them. The rate for PD patients per million population has grown by 24% during the past 10 years. In this paper, physiology of peritoneal dialysis, assessment of peritoneal membrane transport function, updated target of solute removal, and potential complications of peritoneal dialysis will be discussed.
Humans ; Korea ; Membranes ; Peritoneal Dialysis* ; Physiology ; Renal Replacement Therapy

No abstract available.
Acute Kidney Injury ; Humans ; Prognosis ; Renal Replacement Therapy